Johnson & Johnson(NYSE:JNJ) said today it launched the Johnson & Johnson Health Partner platform designed to improve preparations and recovery from knee, hip and weightloss surgeries through personal motivation.
The newly launched platform is designed to aid patients in preparing for surgery and connecting them with their healthcare team for customized care.
The system consists of an education and resource-based website, a mobile application to guide patients through surgery prep and recovery and a care portal for healthcare providers, Johnson & Johnson said.
“Healthcare is personal, and helping people achieve their best health is deeply rooted in our commitment as a healthcare company. Health Partner has been designed with the ‘whole person’ experience in mind to help ensure better engagement between patients and their healthcare team, and get patients back to living their lives – because we know that will help enhance efficiencies and quality of care,” J&J group worldwide chair Sandra Peterson said in a press release.
Johnson & Johnson said the Health Partner platform will look to drive better health and economic outcomes through behavior change strategies based in scientific evidence which aim to increase the likelihood patients patients will follow pre and post-surgical care instructions and become engaged and informed.
“Our collaborative partnership with the Health Partner team had the insights, experience and technology to enable us to strengthen the patient-provider relationship throughout the continuum of care. We believe the ability to customize a patient’s care path to their physical and emotional needs is critical for recovery. We want our patients to go home happy, with restored function and little to no pain,. Health Partner will not only allow our care team to provide critical resources to patients throughout the entire orthopaedic episode of care – pre-op to post-op – but also give the team the ability to monitor patient behavior, track progress and facilitate discussions around results in real-time. We believe this combination will get us to less costly readmissions and post-operative care,” Princeton HealthCare System VP James Demetriades said in a press release.
Late last month, J&J subsidiary DePuy Synthes launched the TFNA augmentation system designed to treat patients with hip fractures who have poor bone quality.
Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.
At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!
Use code WOMENSHEALTH to save an additional 10%.